Updated ASE Code of Ethics and Whistleblower Policies

ASE’s Governance and Compliance Committee, chaired by Neil Weissman, MD, FASE, and co-chaired by Merri Bremer, EdD, RN, ACS, RDCS, FASE, completed their review of ASE’s governance documents and recommended changes to the Society’s Code of Ethics (COE) Policy and Whistleblower Policy. These revisions were approved by the Board of Directors during their 2021 November meeting. The organization wants to support a cohesive and transparent policy, and has placed these new documents on a public-facing site.

All new members will be asked, upon their dues submission, to agree to the new code of ethics guidelines. Renewing members will be a given an opportunity later this Spring. This COE document sets forth the governing principles, values, and beliefs shared by members of the American Society of Echocardiography, as well as the ethical behavior and standards of conduct expected in conformance with these principles and beliefs.

OnlineJASE.com Educational Opportunities

In the newly posted Associate Editor Corner, JASE Editorial Board member and Social Media consultant Jordan Strom, MD, FASE, interviews JASE Associate Editor Mark Friedberg, MD, PhD, FASE, who shares his thoughts on the evolution of pediatric echocardiography, myocardial work in animal models of pulmonary hypertension, and the link between prenatal events and postnatal cardiac function over the entire lifespan of an individual. Watch here.

The new JASE podcast is a special collaboration with the Canadian Society of Echocardiography live journal club. In this episode, Shaheeda Ahmed, MD, and Michael Hammer, MD, join Amer Johri, MD, FASE, to discuss the paper: “Routine Use of Contrast on Admission Transthoracic Echo for Heart Failure Reduces the Rate of Repeat Echo during Index Admission” by Lee et al., with a special introduction from JASE Editor-in-Chief, Michael Picard, MD, FASE.

Three Weeks Left to Submit Your Abstract for ASE 2022

Don’t miss the opportunity to submit your abstract of original science or clinical case report to be considered for presentation at the premier cardiovascular ultrasound conference of the year, the 33rd Annual Scientific Sessions. Submission closes Wednesday, February 9, 2022, at 11:59 PM ET.

ASE abstract presenters benefit from a global audience that promotes future collaborative work, eligibility for grant support, and sharply discounted conference registration rates. Share your important findings with fellow investigators and colleagues, and interact with global leaders in the field. All accepted abstracts are published in the online Journal of American Society of Echocardiography (JASE) issue in June 2022.

ASE Headquarters Closed Monday, Jan 17

ASE Headquarters will be closed Monday, January 17 in observance of the Martin Luther King Jr. Holiday. Normal business hours will resume on Tuesday, January 18.

New ASE Guideline Focuses On The Acquisition Of Essential Transesophaegal Echocardiogram Images For Structural Heart Disease Assessment Before Intervention

As the increasing number of structural heart interventions are assisted by real-time imaging guidance, interventional echocardiography is being recognized as a subspecialty requiring advanced training for intraprocedural guidance. The new guideline document from the American Society of Echocardiography (ASE), Standards for the Performance of Transesophageal Echocardiographic Screening for Structural Heart Intervention, focuses on providing a teaching resource for this growing population of specialists. The guideline elucidates and standardizes the acquisition of essential pre-interventional transesophageal echocardiography (TEE) images to help accurately identify the mechanism of structural/valvular dysfunction, the hemodynamic as well as anatomic severity of the disease, and specific anatomic features to facilitate appropriate device selection or exclusion. This peer-reviewed guideline, created by 14 international echocardiographers who are experts in this emerging field, has been endorsed by 25 ASE International Alliance Partners and is published in the January 2022 issue of the Journal of the American Society of Echocardiography. Read more here.

Submit Your Abstract for ASE 2022

Submit your abstract of original science or clinical case report to be considered for presentation at the premier cardiovascular ultrasound conference of the year, the 33rd Annual ASE Scientific Sessions, scheduled to take place in Seattle, Washington, June 10-13, 2022. Submission closes Wednesday, February 9, 2022, at 11:59 PM ET.

ASE abstract presenters benefit from a global audience that promotes future collaborative work, eligibility for grant support, and sharply discounted conference registration rates. Share your important findings with fellow investigators and colleagues, and interact with global leaders in the field. Learn more here.

Honor Your ASE Mentor with a Named Table at the ASEF’s Annual Research Awards Gala

The ASE Foundation Board is pleased to offer donors a new opportunity to make a donation with name recognition. Donors are invited to purchase naming rights for a table at the Foundation’s Annual Research Awards Gala. For a $5,000 donation, a table may be named in honor or in memory of an ASE luminary (a member with a significant relationship to ASE) for a period of five years. A gift of $35,000 will name that table in perpetuity. All gifts will be treated as a contribution to the Pamela S. Douglas Research Scholar Endowment Fund, and support future Douglas Research Scholar Awards.

To kick off the named tables promotion, ASE has purchased two tables honoring legends Harvey Feigenbaum, MD, FASE, and Liv Hatle, MD, FASE. Please think about honoring your mentor or other luminaries and raising needed funds for research at the same time!

Available tables are limited. Please contact Andrea Van Hoever at AVanHoever@ASEcho.org for more information.

All requests to name a table will be vetted by the ASE Foundation Board, and honorees must agree to a social media screening performed by a third-party vendor. Naming rights do not guarantee location of the table, ownership of the table, a guaranteed seat at the Gala each year, nor discounts on other tables. Attendance at the Gala will require purchase of a ticket or table, but staff will make every effort to match donors’ seating assignments at named tables as possible. 

ASE Headquarters Closed

ASE Headquarters will be closed December 23, 24, 27, 31, and January 3. Thank you in advance for your patience as response times may be delayed due to these office closures. Normal business hours will resume Tuesday, January 4.

New Add-on CPT Code and Value for Three-Dimensional Echocardiography

ASE is proud to see the establishment of Current Procedural Terminology (CPT) add-on code +93319.

This code describes the clinical work involved in 3D echocardiographic imaging and post-processing during transesophageal echocardiography, or during transthoracic echocardiography for congenital cardiac anomalies and includes the assessment of cardiac structures and function (cardiac chambers, valves, left atrial appendage, interatrial septum, and function for example), when performed.

To use this new add-on code and be reimbursed properly, you must list this new CPT code in addition to the appropriate base echocardiography code: congenital transthoracic (CPT codes 93303, 93304) or Transesophageal Echocardiography (CPT codes 93312, 93314, 93315, 93317). It is important to note that this is not an add-on code for CPT code 93355 since this code already includes 3D imaging for guidance of a structural intervention. CPT codes 76376 and 76377 are not add-on codes and are appropriate for reporting 3D-rendering services provided on a date separate from the base-imaging study.

This code, along with the RUC-recommended physician work RVU of 0.50, will be effective on January 1, 2022.

Often it takes time for commercial payers to review and support new technology codes/policies and the associated literature. The COVID-19 pandemic may delay the process even further. ASE suggests that providers always verify with the payers if authorization must be approved in advance.

Questions? Please contact Irene Butler, Vice President of Health Policy & Member Relations.

December CASE – The Gift of Continual Fine-Tuning

The latest issue of CASE, ASE’s open access case reports journal, is available and includes, “Left Ventricular Intramyocardial Dissecting Hematoma,” by Junya Tanabe, MD, Koichi Okazaki, MD, Akihiro Endo, MD, and Kazuaki Tanabe, MD. Vincent L. Sorrell, MD, FASE, CASE Editor-in-Chief, said, “One of the many unique benefits of a digital, case-based journal is the ability to immediately inform healthcare providers of rarely reported deadly findings that may easily be misdiagnosed if not seen before. As the old but accurate adage goes: You can’t diagnose what you don’t know! Dr. Tanabe et al. provide us with an excellent report of a patient with an intramyocardial dissecting hematoma as a complication after an untreated myocardial infarction. The authors include a comprehensive approach to making these diagnoses with echocardiography and include a table with three criteria for the reader’s use. In addition to a discussion into the likely mechanistic explanation, they highlight the commonly misinterpreted diagnoses that may look like this deadly post-infarct complication (e.g., noncompaction, hypereosinophilic syndrome, pseudoaneurysm, or LV thrombus). This case is a wonderful reminder that we always need to expand our knowledge base, and reading case reports is certainly one way to do this.”
Additionally, this issue includes two more rare but deadly finding cases, cases on the complementary role of multimodal imaging, endocarditis, bedside learning with POCUS, congenital heart disease, the role of stress in clinical decision making, a right atrial epidermoid cyst, and the importance of nomenclature. The editorial from Dr. Sorrell, “Does Anyone Remember ‘Fingerprints on an X-ray?‘” is not only a fun read but also elucidates how the ways we should learn are not always obvious.
Visit the CASE Homepage to see the Author Spotlight – Rebecca Hahn, MD, FASE, shares her insights in this brief interview with Dr. Sorrell on her perspective about the new ASE guideline, Recommended Standards for the Performance of Transesophageal Echocardiographic Screening for Structural Heart Intervention.